Table 1 |
||
|
Effects of 1,000 μmol/l sodium ferulate on apoptosis-related gene expression in rat osteoarthritis chondrocytes. |
||
|
Gene |
Model control/normal control (20 ng/ml vs. 0 ng/ml IL-1β) |
SF treatment/model control (1,000 μmol/l vs. 0 μmol/l SF in presence of 20 ng/ml IL-1β) |
|
|
||
|
TNF/TNFR pathway |
||
|
TNF |
30.07 |
0.64 |
|
TNFR-1b |
3.04 |
0.39 |
|
TRAF-2 |
2.50 |
0.43 |
|
TRADD |
1.98 |
0.69 |
|
Caspase-8 |
2.30 |
0.43 |
|
Caspase-3 |
1.88 |
0.46 |
|
NF-κB |
2.55 |
0.56 |
|
Other pathways |
||
|
Fas |
1.85 |
1.00 |
|
Fas ligand |
0.45 |
0.42 |
|
FADD |
0.94 |
0.58 |
|
Bcl-2 |
0.75 |
0.59 |
|
Bax |
0.61 |
0.66 |
|
Bax/Bcl-2 |
0.80 |
1.12 |
|
Apaf1 |
0.76 |
1.03 |
|
Caspase 9 |
0.53 |
0.48 |
|
|
||
|
Each reported value represents the mean fold of mRNA expression relative to the control levels for three biological replicates. FADD, Fas-associated death domain protein; SF, sodium ferulate; TNFR, tumor necrosis factor receptor; TRADD, TNF receptor-associated death domain; TRAF, TNF receptor-associated factor. |
||
|
Qin et al. Arthritis Research & Therapy 2012 14:R242 doi:10.1186/ar4085 |
||